Form 8-K - Current report:
SEC Accession No. 0001096906-25-000518
Filing Date
2025-04-16
Accepted
2025-04-15 17:31:51
Documents
15
Period of Report
2025-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LFTD PARTNERS INC. - FORM 8-K SEC FILING lsfp-20250411.htm   iXBRL 8-K 18699
2 LETTER FROM LFTD PARTNERS INC. DATED APRIL 11, 2025, TERMINATING LETTERS OF INTE lftd_ex99z1.htm EX-99.1 4732
  Complete submission text file 0001096906-25-000518.txt   153278

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsfp-20250411_def.xml EX-101.DEF 1845
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lsfp-20250411_lab.xml EX-101.LAB 20191
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsfp-20250411_pre.xml EX-101.PRE 13397
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsfp-20250411.xsd EX-101.SCH 2307
18 EXTRACTED XBRL INSTANCE DOCUMENT lsfp-20250411_htm.xml XML 2558
Mailing Address 14155 PINE ISLAND DRIVE JACKSONVILLE FL 32224
Business Address 14155 PINE ISLAND DRIVE JACKSONVILLE FL 32224 847-915-2446
LFTD PARTNERS INC. (Filer) CIK: 0001391135 (see all company filings)

EIN.: 870479286 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52520 | Film No.: 25840729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)